New tool helps doctors and patients tackle obesity in diabetes

NCT ID NCT05198765

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tests a web-based tool called the BMI-CDS (Weight Loss Wizard) in 40 primary care clinics. The tool gives doctors and patients with type 2 diabetes and obesity personalized estimates of the benefits and risks of treatments like weight-loss surgery or medication. Over 10,000 adults are taking part to see if the tool leads to more referrals, prescriptions, and better weight loss over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BMI-CDS (Weight Loss Wizard) - a shared decision-support tool
What this could lead to
If successful, this tool could help more patients with diabetes and obesity get effective treatments like weight-loss surgery or medication, leading to better weight management.
What could go wrong
This is a behavioral intervention, not a drug or surgery, so its impact depends on how well doctors and patients use it. Results may vary across clinics and may not lead to long-term weight loss for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HealthPartners Medical Group

    Minneapolis, Minnesota, 55440, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.